Results 1 - 8 of 8 Search Tips

Peripheral blood stem cell transplantation part 1

27 November 1996

Nursing Standard

Cancer nursing

Conventional treatment tor cancer usually consists of surgery, chemotherapy and/or radiotherapy to eradicate malignant cells. Doses of drugs and radiotherapy are...

Peripheral blood stem cell transplantation part 2

04 December 1996

Nursing Standard

Cancer nursing

Multiple cycles of chemotherapy can significantly reduce some tumours. However, doses may be limited due to serious haematological toxicity. White blood cell and...

Hypnotherapy: complementary support in cancer care

17 September 1997

Nursing Standard

Clinical

On occasions, even the most persistent professional may encounter difficulties in gaining control of a patient’s symptoms. Hypnosis is perhaps an unusual nursing...

The value of home support for cancer patients: a study

30 April 1997

Nursing Standard

Art & Science

The Community Oncology Project (COPE) was initiated to investigate home support from a trained oncology nurse at various stages of treatment. Patients who received...

Increasing awareness of survivors’ needs

13 December 2011

Cancer Nursing Practice

General

More people in the UK are surviving cancer, but the long-term effects of treatment and the support that survivors need to have a good quality of life are...

Why ‘watch and wait’ is still a valuable option for low grade lymphomas

08 March 2018

Cancer Nursing Practice

Evidence & practice

In 2016, the National Institute for Health and Care Excellence (NICE) released guidelines recommending people with asymptomatic advanced follicular low grade...

Ready for ramadan

13 July 2010

Nursing Standard

Feature

As the Islamic holy month of Ramadan approaches, one cancer nurse is alerting Muslim patients to the risks of discontinuing treatment.

Exploring the benefits of a home pembrolizumab infusion service for patients with advanced melanoma

06 June 2018

Cancer Nursing Practice

immunotherapy

An increasing incidence of melanoma and recent scientific developments in systemic anti-cancer therapies have resulted in greater demand for immunotherapy, leading...